Please try another search
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Huabiao Wang | 58 | 2015 | CFO & Director |
Dewei Yi | 58 | 2015 | Chairman of the Board & GM |
Chunyu Zhang | 47 | 2021 | Director |
Xiangdong Chen | 60 | 2021 | Independent Director |
Junyu Wu | 38 | 2015 | Employee Supervisor |
Jing Chen | 40 | 2021 | Supervisor |
Qi Liu | 46 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review